Clin Psychopharmacol Neurosci.  2018 Feb;16(1):118-121. 10.9758/cpn.2018.16.1.118.

Risperidone Related Raynaud's Phenomenon: An Adolescent Case

• GüneÅŸ S
• Ekinci O
• Teke H
• Yıldırım V

• KMID: 2405242
• DOI: http://doi.org/10.9758/cpn.2018.16.1.118

Abstract

Raynaud's phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud's phenomenon. Risperidone is an atypical antipsychotic drug with dopaminergic and serotonergic effects. In children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. Here we report a case of Raynaud's phenomenon associated with risperidone in a 12-year-old boy. Raynaud's phenomenon occurred two weeks after starting risperidone and disappeared after stopping risperidone.

Keyword

Raynaud's phenomenon; Risperidone; Adolescent; Child; Case report

MeSH Terms

Adolescent*
Aripiprazole
Bipolar Disorder
Child
Conduct Disorder
Humans
Male
Risperidone*
Schizophrenia
Serotonin Uptake Inhibitors
Stress, Psychological
Tic Disorders
Aripiprazole
Risperidone
Serotonin Uptake Inhibitors